The genetic medicines field is working toward therapies capable of doing their editing work inside the body by reaching many different types of tissue and cell types. Regeneron Pharmaceuticals and ...
Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a new therapeutic pathway for cancers driven by NRAS mutations. Findings ...
Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study and alter neurophysiological processes. These include CRISPR (Clustered ...